Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.

@article{Ghamdi2005StageIN,
  title={Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.},
  author={Abdullah M Al Ghamdi and Michael A. S. Jewett},
  journal={The Canadian journal of urology},
  year={2005},
  volume={12 Suppl 1},
  pages={62-5; discussion 103-4}
}
For patients with clinical stage I nonseminomatous germ cell tumor (NSGCT), the therapeutic options after orchiectomy are retroperitoneal lymphadenectomy, surveillance, and chemotherapy. Ideally the option selected will be based on an individualized assessment of the estimated risk of progression based on prognostic factors, so called risk-adapted treatment, to reduce overall burden of therapy while maintaining survival. It is possible to identify patients at low risk of progression who can be… CONTINUE READING

Similar Papers

Loading similar papers…